Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 41 results found. Search for [ pfizer vaccine efficacy claims ]

Results 1 to 21 of 41
PB Jayakumar
March 3, 2021
So far, the Pfizer-BioNTtech and Moderna vaccines, made through a novel platform technology never used in humans before, are proven to have maximum efficacy


Manoj Sharma
January 5, 2021
There was immense pressure on governments to develop a vaccine at the earliest due to the destruction COVID-19 pandemic was unleashing. This led to a race among pharma companies to be the first to develop a vaccine


PTI
January 2, 2021
While AstraZeneca says it expects 2 million doses of the Oxford University vaccine to be ready each week in just over a fortnight, Pfizer BioNTech said the number of doses it has now sent to the UK is 'in the millions'


BusinessToday.In
December 29, 2020
Poonawalla says Covishield shows efficacy level of 95 per cent provided two shots are taken after a gap of 2-3 months; AstraZeneca will make that public with documentation soon, he adds


BusinessToday.In
December 29, 2020
The chief executive of Serum Institute - the biggest vaccine maker in the world by volume - said all trial data for Covishield has been provided to authorities in the UK and India as \"nobody wants to risk safety\"


BusinessToday.In
December 25, 2020
The SII CEO says considering the high demand for vaccines in the wake of coronavirus, the next decade could be a \"golden one\" for the entire vaccine industry


BusinessToday.In
December 23, 2020
In his latest blog post, Bill & Melinda Gates Foundation co-chairman said his foundation has also taken some of the financial risks on the Oxford-AstraZeneca vaccine and that Serum won't have to take a full loss


BusinessToday.In
December 13, 2020
Last year, the RBI had also made the services of the National Electronic Fund Transfer (NEFT) be available 24*7.


BusinessToday.In
December 13, 2020
As of December 11, Mexico remains the fourth worst-affected country by the pandemic in the world.


BusinessToday.In
December 12, 2020
US President Donald Trump says: \"We've delivered a safe and effective vaccine in just 9 months. This is one of the greatest scientific accomplishments in history\"


PB Jayakumar
December 11, 2020
Sputnik V in India: India's Dr Reddy's Laboratories and Hetero Drugs have a license to sell 100 million doses of the vaccine in India and limited trials are also being done in the country, as part of the approval process


Chitranjan Kumar
December 7, 2020
The WHO said that journalists need to read the full study or report before publishing an article about it and should be willing to question stakeholders and data collection methodology


BusinessToday.In
December 7, 2020
On December 2, the UK became the first nation to approve Pfizer-BioNTech vaccine against COVID-19 for emergency use; Bahrain has also approved vaccine candidate 'BNT162b2'. India decision on vaccine could come this week


BusinessToday.In
December 6, 2020
Pfizer Inc submitted application to DCGI seeking emergency use authorisation on Dec 4; also seeks permission to import vaccine for sale and distribution in India


BusinessToday.In
December 5, 2020
On December 2, the UK became the first country in the world to approve Pfizer and BioNTech coronavirus candidate BNT162b2 after the Medicines and Healthcare Products Regulatory Agency found the jab safe for widespread rollout


BusinessToday.In
December 5, 2020
Confirmation of approval by National Health Regulatory Authority of Bahrain followed thorough analysis and review undertaken by authority of all available data


Vivek Dubey
December 4, 2020
Facebook said, \"Given the recent news that COVID-19 vaccines will soon be rolling out around the world, over the coming weeks we will start removing false claims about these vaccines that have been debunked by public health experts on Facebook and Instagram\"


Manoj Sharma
December 2, 2020
Pfizer and BioNTech vaccine: The UK has already ordered 40 million doses of the Pfizer vaccine to vaccinate its 20 million population, of which around 10 million doses will be available soon


BusinessToday.In
November 30, 2020
As number of patients has doubled from 95 to 196, Moderna has reported a drop in efficacy for its COVID-19 vaccine from 94.5 per cent to 94.1 per cent


BusinessToday.In
November 29, 2020
As coronavirus cases continue to rise, the UK plans to move fast in the approval process and clearance to Pfizer and BioNTech SE could come by next week


PAGES 1 OF 3  123